Denise Scots-Knight, Chief Executive Officer at Mereo BioPharma Group plc (MREO), sold 265,970 shares at $3.69 ($926K) on 2024-06-25, disclosed to the SEC on 2024-06-27.
Open-market sale of $926k MREO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.69 | 40,712 | $150K | 16.2% |
| 2 | $3.69 | 40,712 | $150K | 16.2% |
| 3 | $3.39 | 92,273 | $313K | 33.8% |
| 4 | $3.39 | 92,273 | $313K | 33.8% |
| Total | $3.48 avg | 265,970 | $926K | 100% |